IL6 and obesity disorder: Type 2 diabetes and obesity have characteristics of inflammatory conditions with increased blood levels of pro-inflammatory cytokines, such as interleukin (IL)-6, IL-1 and TNF-α [42], which attenuate insulin receptor signaling [43].